scPharmaceuticals Inc. SCPH

Full chart Compare
Set alert

Price alert · SCPH

All alert types
5.67 0.00 (+0.00%)

At closeOct 7, 2025, 4:00 PM EDT

5.67 Day range 5.67

52-week range unavailable

YTD
+60.17%
1 year
+32.48%

Revenue & Expenses

Revenue → Gross Profit: $24.97MGross Profit → Expenses: $24.97MRevenue → Cost of Revenue: $11.36MExpenses → Selling, General & Admin: $77.65MExpenses → Research & Development: $12.10MExpenses → Interest Expense: $7.57MExpenses → Other Expenses: $12.80MNet Loss → Expenses: $85.15MGross Profit$24.97MNet Loss$85.15MCost of Revenue$11.36MExpenses$110.12MSelling, General & Admin$77.65MResearch & Development$12.10MInterest Expense$7.57MOther Expenses$12.80MRevenue$36.33M

Latest period ending Dec 31, 2024 · select a line to chart its full history

SCPH annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
36.33M13.59M000
24.97M9.78M000
-64.78M-55.40M-36.16M-25.82M-29.93M
-85.15M-54.81M-36.84M-28.03M-32.21M
-1.91-1.42-1.30-1.02-1.31
SCPH annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
75.66M46.81M71.24M74.45M72.00M
107.52M94.48M124.19M79.04M109.05M
94.20M57.26M51.76M22.57M26.88M
79.56M40.27M37.37M17.64M20.21M
13.32M37.22M72.43M56.47M82.17M
SCPH annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-70.54M-59.24M-34.58M-27.15M-27.69M
29.30M19.96M-45.86M32.13M-33.46M
70.08M14.85M77.23M-2.53M60.35M
-21.00K-40.00K-21.00K-9.00K0
28.84M-24.43M-3.21M2.45M-805.00K